MT1DP and central nervous system cancer: Our previous studies showed that MTM was significantly up-regulated in glioma cells after WZY-321 treatment, further overexpression of MTM markedly down-regulated the content of miR-873, suggesting that MTM may cause miR-873 degradation through binding to miR-873.